Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma - Wikidata - awgldk - TriplyDB

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma

http://www.wikidata.org/entity/Q34628523

about

Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression The genetic basis for inactivation of Wnt pathway in human osteosarcoma.YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.The genetics of osteosarcoma.Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression.High level of αB-crystallin contributes to the progression of osteosarcoma Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor.Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma.Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.Prediction of optimal gene functions for osteosarcoma using network-based- guilt by association method based on gene oncology and microarray profile Gene expression profiling analysis of osteosarcoma cell lines.Prospective Preliminary In Vitro Investigation of a Magnetic Iron Oxide Nanoparticle Conjugated with Ligand CD80 and VEGF Antibody As a Targeted Drug Delivery System for the Induction of Cell Death in Rodent Osteosarcoma Cells.Inhibition of Growth and Metastasis of Tumor in Nude Mice after Intraperitoneal Injection of Bevacizumab.miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer.Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor.VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities.Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.

P2860

Q26782646-0542F831-4A1B-4709-B407-A97E5AC1CF68 Q26829949-89E0A413-0063-463C-8282-A3DD251EBD31 Q33818604-9CB3BFD2-31CC-42EA-B9BB-EF3BD8D9BF16 Q34065323-55703D79-3719-4701-934C-68993B6869DE Q34340295-3F1F2D17-0B7F-4BB0-A448-B56E3BF82DD3 Q34639086-E8D6462A-DBF4-4DA7-AFF7-DBB4DBF9119B Q35020434-2EEF1C8D-9200-49EE-9624-6D0F8F2CFB46 Q35065555-D0C549C3-6381-40A3-AE5F-895D91383675 Q35552532-CF407000-5F4E-48EC-B0D4-ADC8CB753551 Q35770577-5EE3C093-11C3-4C3D-BB3E-298333F7F482 Q35833089-A387F995-F358-469A-B52D-E5B8D6D18125 Q36071047-B68E5A0F-BC0E-4C25-AE59-85A47666D828 Q36557338-7212AA8C-BAC9-4B87-9ABE-BFA666D13C8B Q36620774-5479BDD3-342A-4CE6-A7CA-201A6E80AD32 Q36962484-A9F30C78-6B68-4E56-A0C5-4944C1B42259 Q37225517-CEAFDDA6-C802-433B-8B28-EB3433D4CCD2 Q37427132-1289C09A-C375-4441-BD99-F3DF190B9E95 Q37565250-9256E817-A5B8-49DC-8197-D739CFD90E6B Q37740672-A2FA6C3B-D214-4FFB-AD41-444230F1CC04 Q37944599-04CB9D1F-BF01-4127-8416-75B2EB643949 Q38084245-30347D24-95A5-4A30-A962-86F80CE169A2 Q38099265-37250A5A-83DE-49AF-9D6E-ADF9D5AED494 Q38434316-3A451859-6FE5-4FA8-A345-F5BE3AE8261E Q38461663-5FBEA4EA-E0C9-4DAE-B390-FE252C8843D2 Q38731083-0D80F391-33D1-487F-B577-8C7262DB437D Q38759471-D3159E65-6ECB-4C14-829D-9CEFDDDEE857 Q38833391-FBB9FE50-E2AE-435D-9923-3736172F2E3C Q39401628-23625241-6417-429B-93BB-A1B152864837 Q43708400-759263C6-BA79-47AA-92F9-F7BA430F0C87 Q44122884-6B80C0F8-75CC-4AF8-BD18-9094AFA03414 Q44354395-A1FFEEFE-1FB7-440E-B39C-607C0DA02CF0 Q46126845-187F36C0-29C4-40DA-80BF-A3347B2CBB83 Q51779979-7AC9C137-1357-470E-BD0A-31FC5B0DAC07 Q52779937-7A2EEC7F-9850-41F2-8E7D-AC17E2A1B49A Q53136378-5AC2B617-4598-4425-B135-9AD93D7D85E5 Q55177521-012C6344-F74D-486C-9EA5-0835070FBBFF

P2860

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma

http://www.wikidata.org/entity/Q34628523

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@ast

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@en

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@nl

type

label

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@ast

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@en

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@nl

prefLabel

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@ast

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@en

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@nl

P1433

Q34628523-0864A6CC-59D7-43CB-9A10-18850A35BFD2

P1476

Q34628523-433DBD97-221F-442E-8E91-6F51AE2E90CF

P2093

Q34628523-0EA09F55-F0EC-4DB8-A38B-1EA1A09CEF67

Q34628523-1F60CA4C-F320-406A-B9D5-3F902F3A5DAF

Q34628523-24D9E043-5304-41CD-A7DD-D97E41A0FEA1

Q34628523-2DFE4C1F-809E-4081-8033-98559A5F6CE1

Q34628523-A1244C73-17B9-4B1F-9758-D650125B7849

Q34628523-AF69E292-22ED-4CDF-B9A8-E3F60DC54103

Q34628523-C2E4E5CE-5D8B-4E2F-B1BB-F2AEC09BD422

Q34628523-CDA245C0-0693-40CF-A1D5-910EFD719E7B

Q34628523-D420DA22-2EC2-4681-A2B3-A62C9E04B693

P2860

Q34628523-000391B6-6320-4B04-BB48-530945F660F0

Q34628523-09AFB97B-44BD-4734-876C-25A1CE00322B

Q34628523-0FE39C79-6AD1-48EA-949E-9ACEBC5AC192

Q34628523-16C3E619-A06A-4D6B-BBBE-AD56A841C538

Q34628523-230B165A-8F1D-4937-A93E-8ECB620D40D4

Q34628523-2D064BE5-330E-4004-9933-A1BAE3641189

Q34628523-2EDE8FBB-DCF3-4616-92F1-E44F06856EF0

Q34628523-36F02AEC-212D-4BAA-AEBD-35BF098E077E

Q34628523-414B061B-2E3B-4EFD-ABCD-D44AB364D41E

Q34628523-4417874D-53A8-4473-BC3B-055AE08B02F5

P304

Q34628523-CA9DE3A9-51E2-44B0-ACAA-D30556EE9157

P31

Q34628523-C44BE6AE-E280-4C15-9F18-1AADBDC7AB6D

P356

Q34628523-81B7A6DD-EDB8-45F3-B5EB-40B0925ECA91

P407

Q34628523-09B48648-7E63-4879-818F-51199062D129

P433

Q34628523-D45E3D5F-8166-426E-B59D-148C406F9570

P478

Q34628523-9852D192-7D95-4A8C-A55A-9843BE7FC43B

P577

Q34628523-FADDFD6B-3241-4E06-B43B-C12B27FD4758

P5875

Q34628523-8BAEA9FB-35BA-459F-B196-91A8A810A1F5

P698

Q34628523-D7AE5CFD-6A40-4224-A8CD-3D3FA55C14D0

P921

Q34628523-B4363C11-B84A-4CF7-8A31-F4533AAC04D7

P932

Q34628523-D394020C-7F86-4ACB-9FFC-A468522471EB

P356

P1433

P1476

Genetic amplification of the v ...... g VEGFA, in human osteosarcoma

@en

P2093

Baocun Sun

http://www.w3.org/2001/XMLSchema#string

Da Yang

http://www.w3.org/2001/XMLSchema#string

Dejka M Araujo

http://www.w3.org/2001/XMLSchema#string

Guowen Wang

http://www.w3.org/2001/XMLSchema#string

Jilong Yang

http://www.w3.org/2001/XMLSchema#string

Jonathan C Trent

http://www.w3.org/2001/XMLSchema#string

Kexin Chen

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

Circular binary segmentation for the analysis of array-based DNA copy number data

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Weighted clustering of called array CGH data.

Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma.

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.

Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).

Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.

P304

4925-4938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.26116

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51053064

http://www.w3.org/2001/XMLSchema#string

P698

21495021

http://www.w3.org/2001/XMLSchema#string

P921

P932

3465081

http://www.w3.org/2001/XMLSchema#string